Literature DB >> 10818887

Compression wraps for venous ulcer healing: a review.

S A Kramer1.   

Abstract

Compression to the lower extremities is used to increase healing of venous stasis ulcers by improving the blood supply and reducing edema and distension. Compression wraps are available in elastic or non-elastic and in single to multilayer systems requiring varying types of application and exerting different levels of compression. Elimination of edema is so basic and important to venous ulcer healing that the most effective level of compression should be used. Controversy exists regarding the most effective sub-bandage pressure (ranging from 20 mm Hg to 45 mm Hg) for timely healing. Because of differences in compression wraps, selection of the most effective and efficient wrap can be difficult. The purpose of this integrated review was to determine healing rates of venous ulcers with various wraps. The studies reviewed provide reasonable evidence that venous ulcers can be healed with the use of compression wraps and that various wraps are effective when used with correct assessment, application, and fit by the caregiver, along with compliance and mobility of the patient.

Entities:  

Mesh:

Year:  1999        PMID: 10818887     DOI: 10.1016/s1062-0303(99)90034-1

Source DB:  PubMed          Journal:  J Vasc Nurs        ISSN: 1062-0303


  3 in total

1.  Subepidermal moisture surrounding pressure ulcers in persons with a spinal cord injury: a pilot study.

Authors:  Jeffrey John Harrow; Harvey N Mayrovitz
Journal:  J Spinal Cord Med       Date:  2014-11       Impact factor: 1.985

2.  Use of a Novel Two-layer Bandage in the Treatment of Chronic Venous Hypertension.

Authors:  Eric J Lullove; Elizabeth Newton
Journal:  J Am Coll Clin Wound Spec       Date:  2014-06-04

3.  Comparison of the effectiveness of compression stockings and layer compression systems in venous ulceration treatment.

Authors:  Maria T Szewczyk; Arkadiusz Jawień; Katarzyna Cierzniakowska; Justyna Cwajda-Białasik; Paulina Mościcka
Journal:  Arch Med Sci       Date:  2010-10-26       Impact factor: 3.318

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.